{
    "clinical_study": {
        "@rank": "4781", 
        "arm_group": {
            "arm_group_label": "Hair removal", 
            "arm_group_type": "Experimental", 
            "description": "hair removal treatment using 805nm LightSheer Duet HS handpiece"
        }, 
        "brief_summary": {
            "textblock": "-  The study will re-confirm that the LightSheer Duet HS 805 nm handpiece is safe for\n           removal of unwanted hair, and will result in hair removal and permanent hair count\n           reduction.\n\n        -  Twenty (20)subjects, Fitzpatrick Skin Type I-IV will be included in a single site.\n\n        -  Each subject will receive five treatments at four to six week intervals and return for\n           follow-up visits at three and six months after the last treatment for evaluation of the\n           treated areas."
        }, 
        "brief_title": "Clinical Evaluation of LightSheer Duet 805nm HS Handpiece", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Hair Removal", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Able to read, understand and provide written Informed Consent;\n\n          2. Healthy adult, male or  female, 18 years of age or older with skin type I-IV;\n\n          3. Having a suitable treatment area for hair removal;\n\n          4. Able and willing to comply with the treatment/follow-up schedule and requirements;\n\n          5. Women of child-bearing potential (women who have not had a hysterectomy, bilateral\n             oophorectomy or are not postmenopausal) are required to be using a reliable method of\n             birth control at least three months prior to enrollment and throughout the course of\n             the study.\n\n        Exclusion Criteria:\n\n          1. Pregnant, expectation of pregnancy, postpartum or nursing (<6 months);\n\n          2. Hormonal disorders that may affect hair growth;\n\n          3. Immunosuppressive diseases, including AIDS and HIV infection, or use of\n             immunosuppressive medications;\n\n          4. Livedo reticularis;\n\n          5. Uncontrolled systemic diseases such as diabetes;\n\n          6. Active infections in the treated area;\n\n          7. Dysplastic nevi;\n\n          8. Significant concurrent skin conditions or any inflammatory skin conditions;\n\n          9. Active cold sores, open lacerations or abrasions;\n\n         10. Chronic or cutaneous viral, fungal, or bacterial diseases;\n\n         11. Current cancer;\n\n         12. History of skin cancer or pre-cancerous lesions at the treatment areas;\n\n         13. Use of Accutane\u2122 (Isotretinoin) within the past six month;\n\n         14. Keloid formation in the treatment area;\n\n         15. Tattoos in the treatment area;\n\n         16. Bleeding coagulopathies or use of anticoagulants;\n\n         17. Auto-immune disorders;\n\n         18. Erythema ab igne, when identified treatments should be discontinued;\n\n         19. Photosensitivity disorder that can be exacerbated by laser or intense light;\n\n         20. Herpes simplex in the treatment area;\n\n         21. Use of medications, herbal supplements, perfumes or cosmetics that may affect\n             sensitivity to light;\n\n         22. Poor wound healing;\n\n         23. Sunburns;\n\n         24. Unable or unlikely to refrain from artificial tanning, including the use of tanning\n             booths, prior (at least a week) and during the course of the evaluation;\n\n         25. Prior skin treatment with laser or other devices on the same treated areas within the\n             last six months prior to study enrollment or during the course of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01801202", 
            "org_study_id": "LUM-ABU-HS 805nm-12-01"
        }, 
        "intervention": {
            "arm_group_label": "Hair removal", 
            "description": "The approach to be studied here relies on a cleared modality, the LightSheer Duet High Speed (HS) that uses 805 nm diode laser with vacuum (K053628).", 
            "intervention_name": "LightSheer Duet HS handpiece", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "July 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sacramento", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95816"
                }, 
                "name": "Laser & Skin Surgery Medical Group Inc"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Evaluation of LightSheer Duet 805nm HS Handpiece", 
        "overall_official": {
            "affiliation": "Laser & Skin Surgery Medical Group Inc", 
            "last_name": "Suzanne Kilmer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "To evaluate the safety of hair removal using the LightSheer Duet HS 805 nm handpiece", 
                "measure": "Number of subjects with Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }, 
            {
                "description": "To verify hair removal and permanent hair reduction using the LightSheer Duet HS 805 nm handpiece", 
                "measure": "Hair count", 
                "safety_issue": "No", 
                "time_frame": "6 monts follow up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01801202"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate subject's assessment of comfort associated with treatments", 
                "measure": "Subject's comfort using VAS", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline, 4, 8, 12, 16 weeks;"
            }, 
            {
                "description": "To evaluate subject's satisfaction with hair removal treatments and assessment of improvement using subject's questionnaire", 
                "measure": "Asses subject's perception of improvement and satisfaction", 
                "safety_issue": "No", 
                "time_frame": "8, 16 weeks following baseline; 3 and 6 monts follow up"
            }
        ], 
        "source": "Lumenis Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lumenis Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}